Ambrisentan and hypervolaemia Patient Reports February 11, 2012

Ambrisentan Side Effects Report #5385897-3
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Male patient, weighting 188.7 lb, was diagnosed with pulmonary hypertension , dyspnoea, prophylaxis, fluid retention and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: hypervolaemia, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with DIGOXIN, ALBUTEROL, WARFARIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE, OXYGEN, FUROSEMIDE. Patient was hospitalized. Patient recovered.

Ambrisentan Side Effects Report #5400988-6
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, weighting 269.0 lb, was diagnosed with pulmonary hypertension  and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: atrial fibrillation , hepatic enzyme increased, hypervolaemia, right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, SILDENAFIL CITRATE, WARFARIN, FUROSEMIDE, LISINOPRIL, DILTIAZEM, GLIPIZIDE, SALSALATE. Patient was hospitalized. Patient recovered.

Ambrisentan Side Effects Report #5860234-6
Ambrisentan side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2008. Male patient, weighting 185.4 lb, was diagnosed with pulmonary arterial hypertension and was treated with Ambrisentan. After drug was administered, patient experienced the following side effects: dizziness , haematochezia, hyperkalaemia, hypervolaemia, pneumonia , right ventricular failure. Ambrisentan dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE. Patient was hospitalized. Patient recovered.